ArticleNMR in biomedicine2026
A Reproducible MRI-Based Pipeline for Longitudinal Tracking of Laser-Assisted Bioprinted Cells in Three-Dimensional Constructs.
Article in NMR in biomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Laser-assisted bioprinting (LAB) enables precise spatial patterning of living cells within three-dimensional constructs; however, the lack of non-destructive, standardised methods for longitudinal evaluation remains a major limitation to construct optimisation and translation. Magnetic resonance imaging (MRI) offers unique advantages for volumetric and repeated imaging due to its non-invasiveness, yet its application to complex multilayer bioprinted constructs has not been systematically assessed using quantitative workflows. In this study, we developed and evaluated an MRI-based pipeline for the longitudinal tracking and quantitative analysis of laser-assisted bioprinted cells within three-dimensional constructs of increasing architectural complexity. Iron oxide-labelled endothelial cells were bioprinted onto gelatin-based biopapers in predefined patterns and assembled into constructs composed of three, six or nine stacked layers. Constructs were monitored at 4.7 T using a high-resolution three-dimensional steady-state free precession sequence for up to 35 days, and quantitative image analysis was independently performed by three operators using the open-source 3D Slicer image computing platform. MRI enabled clear visualisation of printed patterns and multilayer architectures over time due to the signal drop induced by iron oxide particles. Quantitative analysis demonstrated high inter-operator reproducibility and revealed construct thickness-dependent differences in volume and signal-to-noise ratio. As a proof of concept, stacked bioprinted constructs were additionally visualised post-mortem in a murine calvarial defect model, enabling discrimination of individual layers and printed patterns. Together, these results establish MRI as a robust, non-destructive tool for the longitudinal evaluation of complex laser-assisted bioprinted constructs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.